Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin

M. Raffaele, K. Kovacovicova, J. Frohlich, O. Lo Re, S. Giallongo, JA. Oben, M. Faldyna, L. Leva, AG. Giannone, D. Cabibi, M. Vinciguerra

. 2021 ; 19 (1) : 44. [pub] 20210408

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012477

Grantová podpora
CZ.02.1.01/0.0/0.0/15_003/0000492 European Social Fund
NV18-03-00058 Ministerstvo Zdravotnictví Ceské Republiky (CZ)
RO0518 Ministerstvo Zemědělství
856871 Horizon 2020 Framework Programme

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCC is a leading cause of cancer-related death. An increased number of senescent cells correlate with age-related tissue degeneration during NAFLD-induced HCC. Senolytics are promising agents that target selectively senescent cells. Previous studies showed that whereas a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced NAFLD in mice, D + Q lacked efficacy in removing doxorubicin-induced β-gal-positive senescent cells in human HCC xenografted mice. Whether D + Q has an effect on the age-associated spectrum of NAFLD-inflammation-HCC remains unknown. METHODS: Here, we utilized an established model of age- and obesity-associated HCC, the low dose diethylnitrosamine (DEN)/high fat diet (HFD), a regimen promoting liver inflammation and tumorigenesis over a long period of 9 months. Four groups of mice each were created: group 1 included control untreated mice; group 2 included mice treated with D + Q; group 3 included mice undergoing the DEN/HFD protocol; group 4 included mice undergoing the DEN/HFD protocol with the administration of D + Q. At the end of the chemical/dietary regimen, we analyzed liver damage and cell senescence by histopathology, qPCR and immunoblotting approaches. RESULTS: Unexpectedly, D + Q worsened liver disease progression in the DEN/HFD mouse model, slightly increasing histological damage and tumorigenesis, while having no effect on senescent cells removal. CONCLUSIONS: In summary, using an animal model that fully recapitulates NAFLD, we demonstrate that these compounds are ineffective against age-associated NAFLD-induced HCC. Video Abstract.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012477
003      
CZ-PrNML
005      
20220506130422.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12964-021-00731-0 $2 doi
035    __
$a (PubMed)33832488
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Raffaele, Marco $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. marco.raffaele@fnusa.cz $1 https://orcid.org/0000000192324587
245    10
$a Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin / $c M. Raffaele, K. Kovacovicova, J. Frohlich, O. Lo Re, S. Giallongo, JA. Oben, M. Faldyna, L. Leva, AG. Giannone, D. Cabibi, M. Vinciguerra
520    9_
$a BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCC is a leading cause of cancer-related death. An increased number of senescent cells correlate with age-related tissue degeneration during NAFLD-induced HCC. Senolytics are promising agents that target selectively senescent cells. Previous studies showed that whereas a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced NAFLD in mice, D + Q lacked efficacy in removing doxorubicin-induced β-gal-positive senescent cells in human HCC xenografted mice. Whether D + Q has an effect on the age-associated spectrum of NAFLD-inflammation-HCC remains unknown. METHODS: Here, we utilized an established model of age- and obesity-associated HCC, the low dose diethylnitrosamine (DEN)/high fat diet (HFD), a regimen promoting liver inflammation and tumorigenesis over a long period of 9 months. Four groups of mice each were created: group 1 included control untreated mice; group 2 included mice treated with D + Q; group 3 included mice undergoing the DEN/HFD protocol; group 4 included mice undergoing the DEN/HFD protocol with the administration of D + Q. At the end of the chemical/dietary regimen, we analyzed liver damage and cell senescence by histopathology, qPCR and immunoblotting approaches. RESULTS: Unexpectedly, D + Q worsened liver disease progression in the DEN/HFD mouse model, slightly increasing histological damage and tumorigenesis, while having no effect on senescent cells removal. CONCLUSIONS: In summary, using an animal model that fully recapitulates NAFLD, we demonstrate that these compounds are ineffective against age-associated NAFLD-induced HCC. Video Abstract.
650    _2
$a stárnutí $x genetika $x patologie $7 D000375
650    _2
$a zvířata $7 D000818
650    _2
$a dasatinib $x škodlivé účinky $7 D000069439
650    _2
$a dieta s vysokým obsahem tuků $7 D059305
650    _2
$a diethylnitrosamin $7 D004052
650    _2
$a modely nemocí na zvířatech $7 D004195
650    12
$a progrese nemoci $7 D018450
650    _2
$a regulace genové exprese $7 D005786
650    _2
$a nemoci jater $x krev $x genetika $x patologie $7 D008107
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a nealkoholová steatóza jater $x krev $x genetika $x patologie $7 D065626
650    _2
$a obezita $x krev $x genetika $x patologie $7 D009765
650    _2
$a quercetin $x škodlivé účinky $7 D011794
650    _2
$a léky proti stárnutí $x škodlivé účinky $7 D000089322
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kovacovicova, Kristina $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Frohlich, Jan $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Lo Re, Oriana $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Giallongo, Sebastiano $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Oben, Jude A $u Institute for Liver and Digestive Health (ILDH), Division of Medicine, University College London (UCL), London, UK
700    1_
$a Faldyna, Martin $u Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Leva, Lenka $u Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Giannone, Antonino Giulio $u Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Pathologic Anatomy Unit-University of Palermo, Palermo, Italy
700    1_
$a Cabibi, Daniela $u Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Pathologic Anatomy Unit-University of Palermo, Palermo, Italy
700    1_
$a Vinciguerra, Manlio $u International Clinical Research Center, St. Anne's University Hospital, Brno, Czech Republic. manlio.vinciguerra@fnusa.cz $u Institute for Liver and Digestive Health (ILDH), Division of Medicine, University College London (UCL), London, UK. manlio.vinciguerra@fnusa.cz $u ERA Chair in Translational Stem Cell Biology, Medical University of Varna, Varna, Bulgaria. manlio.vinciguerra@fnusa.cz
773    0_
$w MED00008216 $t Cell communication and signaling : CCS $x 1478-811X $g Roč. 19, č. 1 (2021), s. 44
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33832488 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130414 $b ABA008
999    __
$a ok $b bmc $g 1789892 $s 1163678
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 19 $c 1 $d 44 $e 20210408 $i 1478-811X $m Cell communication and signaling $n Cell Commun Signal $x MED00008216
GRA    __
$a CZ.02.1.01/0.0/0.0/15_003/0000492 $p European Social Fund
GRA    __
$a NV18-03-00058 $p Ministerstvo Zdravotnictví Ceské Republiky (CZ)
GRA    __
$a RO0518 $p Ministerstvo Zemědělství
GRA    __
$a 856871 $p Horizon 2020 Framework Programme
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...